TP53 Mutations Are Associated With Increased Pathologic Complete Response in HER2-Positive BC

Article Information

DOI 
http://dx.doi.org/10.1177/1559897715571070
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 SAGE Publications

Author Information

  1. Lynne Lederman
  1. Katherine A. Hoadley, PhD
    1. University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015900
May 2015100
Jun 20151200
Jul 2015100
Aug 20155000
Sep 20157900
Oct 2015143
Nov 20151131
Total16474

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
TP53 Mutations Are Associated With Increased Pathologic Complete Response in HER2-Positive BC
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

neoadjuvant
combination treatment
mutational analysis
stage 2
stage 3
trastuzumab
lapatinib
paclitaxel
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
CALGB 40601
NCT00770809